; Biohacking Market Size, Industry Share, Forecast, 2032

Biohacking Market

Biohacking Market Size, Share, and Analysis, By Product (Wearables, Strains, Smart Drugs, Others), By Application (Monitoring, Treatment, Research, Others), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Forensic Laboratories, Research & Academic Institutes, Others) and Regional Forecasts, 2022-2032

Published on: Sep-2023
Report Code: FG HC 01647
No. of Pages: 170-350
Report Format: PDF

Product Overview

Biohacking Market size was USD 17.45 billion in 2021 and projected to grow from USD 24.5 billion in 2023 to USD 115.6 billion by 2032, exhibiting a CAGR of 18.8% during the forecast period.

Biohacking, in simple terms, is referred as ‘do-it-yourself’ biology. For most biohackers, this comprises making small lifestyle or diet changes to make minor improvements in well-being and overall health. Biohacks hold the potential for anything from rapid loss of weight to improved function of the brain. But ideal biohacking impacts come from being knowledgeable and careful about what works for an individual’s body.

Market Highlights

Biohacking Market is expected to project a CAGR of 18.8% during the forecast period, 2022-2032

Biohacking Market is expected to reach USD 115.6 billion, growing at a CAGR of 18.8% during the forecast period owing to the increasing demand for smart or intelligent devices and growing cases of chronic disorders. Also, rising research and development funding by the government and pharmaceutical companies are expected to boost the growth of Biohacking Market over the forecast period.

 

Biohacking Market Segmentation:

Smart Drugs segment is expected to dominate in the forecast period

Biohacking Market is classified based on the Product into Wearables, Strains, Smart Drugs, and Others. The Wearables segment registered a major market share in 2020 owing to the increased use of wearable devices like patches, smartwatches, smart rings, etc. The Smart Drugs category is projected to account for the significant share by 2028 owing to greater demand for such drugs since they have memory boosting potential.

Pharmaceutical & Biotechnology Companies segment is expected to dominate in the forecast period

Biohacking Market is classified based on the End User into Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Forensic Laboratories, Research & Academic Institutes, and Others. The Pharmaceutical & Biotechnological Companies category held a major market share in 2021 and is projected to lead during the estimated period. This is majorly due to the rising elderly population. Also, expanding demand for monitoring devices for sugar level (blood), heart rate, and the body movement is booming the category growth.

 

 

 

Market Dynamics:                                                    

Growth Drivers

Rise in Chronic Disorders and Growing Awareness for Biohacking is Expected to Boost the Market Growth

The Biohacking Market is being considerably driven by the rise in chronic diseases, the demand for intelligent gadgets and medications, and knowledge about biohacking. In the projected period, number of prospects are predicted for market growth due to the sharp rise in chronic diseases among the aging population. Further, researchers and scientists carry out various laboratory experiments to invent new paths in molecular biology, genetic engineering, and biotechnology. Biohackers perform a variety of experiments on the human body like adding microphones or keeping an eye on heart rate. Brain sensors, RFID implants, smart medications, yeast and bacterial strains, microchips, magnetic fingertips, and health monitors are some of the key goods developed due to trials.

Major Technological Advancements and Penetration of IoT in Healthcare and Consumer Electronics are Expected to Boost the Market Growth

Widespread adoption of Internet of Things (IoT) in healthcare and consumer electronics, along with significant technological advancement, has boosted the industry growth. Moreover, the growing cases of chronic illnesses and the rising need for smart medicines and medical equipment to meet the population's expectations for high-quality healthcare are anticipated to support market growth.

Restraint

Stringent Regulation and Lack of Cyber Security Practices to Restrain the Market Growth

The Biohacking Market is anticipated to be constrained by stringent laws governing genetic engineering experiments, a lack of funding for research, a lack of competence, and a lack of cyber security procedures during the forecast period. The fact that these biohacking gadgets interface with one other and transmit data directly to patients' medical records via web services is another major challenge. A hacker might change the data entered into the medical database since many web services are not verified or encrypted between devices.

Recent Developments:

  • Intraxon Inc. introduced the Muse S (Gen 2) headband, a new model of the native Muse S headband, in October 2021. A series of sensors that rest against user’s forehead allow this meditation and sleep tracker aid to measure brain activity.
  • Fitbit partnered with Scripps Research and Stanford Medicine in April 2020 to research how wearables can be used to track, find, and contain infectious viruses like Coronavirus.

Biohacking Market Key Players Covered:

  • Apple Inc.
  • Fitbit Inc.
  • OsteoStrong
  • Dave Asprey
  • Muse (Interaxon Inc.)
  • Soylent
  • Primal Life Organics
  • Neurohacker Collective
  • HVMN Inc.
  • SQLAB Clinic
  • Kaatsu Global
  • The ODIN
  • Grindhouse Wetware
  • Synbiota
  • Biohacking ORB
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Biohacking Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The Biohacking Market is currently dominated by North America since more governments are investing in research and development. Moreover, during the projected period, the region's Biohacking Market would progress even more due to the increasing utilization of synthetic biology. Asia-Pacific is predicted to witness significant market growth due to the presence of technologically advanced healthcare infrastructure. Furthermore, the market in the region would also rise in the coming years due to the appropriate government initiatives and extensive research and development events in the emerging nations.

 

 

 

 

Impact of Covid-19 on Biohacking Market

The COVID-19 virus outbreak had a favorable impact on the biohacking market. The COVID-19 crisis caused the pharmaceutical industries' markets to grow rapidly. Companies have engaged in a number of R&D initiatives to create acceptable medications or vaccinations to stop the epidemic, which, if successful, would boost the market's growth. Governments of major biohacking players are increasing expenditure in these sectors so that pharmaceutical companies can develop effective treatments to contain and eventually destroy the virus.

Biohacking Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Biohacking Market Scope and Segments:

ATTRIBUTE

  DETAILS

Study Period

2018-2032

Base Year

2022

Forecast Period

2022-2032

Historical Period

2019-2021

Growth Rate

CAGR of 18.8% from 2022-2032

Unit

Value (USD Billion)

Segmentation

Main Segments List

Product

  • Wearables
  • Strains
  • Smart Drugs
  • Others

Application

  • Monitoring
  • Treatment
  • Research
  • Others

End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Forensic Laboratories
  • Research & Academic Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions (FAQ):

Biohacking Market size was estimated at USD 17.45 billion in 2021 and is expected to reach USD 115.6 billion in 2032.

Biohacking, in simple terms, is referred as ‘do-it-yourself’ biology. For most biohackers, this comprises making small lifestyle or diet changes to make minor improvements in well-being and overall health.

Smart Drugs and Pharmaceutical & Biotechnology Companies segments accounted for the largest Biohacking Market share

Key players: Apple Inc., Fitbit Inc., OsteoStrong, Dave Asprey, Muse (Interaxon Inc.), Soylent, Primal Life Organics, Neurohacker Collective, HVMN Inc., SQLAB Clinic, Kaatsu Global, The ODIN, Grindhouse Wetware, Synbiota, Biohacking ORB, and Other Prominent Players are the key players in the Biohacking Market.

Rising use of Biohacking practices by users and number of initiatives undertaken by key players are the factors driving the Biohacking Market.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients